Cetera Investment Advisers Bausch Health Companies Inc. Transaction History
Cetera Investment Advisers
- $55.9 Billion
- Q2 2025
A detailed history of Cetera Investment Advisers transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 19,849 shares of BHC stock, worth $131,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,849
Previous 11,447
73.4%
Holding current value
$131,995
Previous $74,000
78.38%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BHC
# of Institutions
248Shares Held
240MCall Options Held
2.46MPut Options Held
8.42M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$231 Million2.99% of portfolio
-
Goldentree Asset Management LP New York, NY34.3MShares$228 Million23.91% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny32.8MShares$218 Million11.35% of portfolio
-
Nomura Holdings Inc Tokyo, M021.5MShares$143 Million0.31% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$86.5 Million0.18% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.41B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...